Clinical study to evaluate the Efficacy and safety of NONIZHI in patients with Bronchial asthma and Malnutrition

DXN Manufacturing India Pvt Ltd0 个研究点目标入组 12 人开始时间: 待定最近更新: 2021年11月24日

试验速览

暂无简介。

•Patients aged 18-59 years(both sex) suffering from mild and moderate-persistent bronchial asthma characterized by
•-Daily symptoms of asthma
•-Nocturnal awakenings more than once per week
•-Daily need for SABAs for symptom relief
•-More than just minor limitation in normal activity
•-FEV1 between 60 and 80 percent of predicted and an FEV/FVC ratio less than the lower confidence interval for normal

•-Patients with fever, drug-induced asthma, aspirin intolerance triad, asthma with fixed airflow limitation, asthma with obesity, late-onset asthma will be excluded.
•-History of heart, liver, kidney, or other organ diseases;
•-Allergy or intolerance to the individual constituents in NONIZHI
•-Subjects who are pregnant and lactating mothers, or with any serious or invalidating other disease limiting full adhesion to the protocol.
•-Participation in an investigational drug trial in the 30 days prior to the screening visit.

发起方

DXN Manufacturing India Pvt Ltd